Delivery Order SPE2DB22D1017-SPE2DB25FG9QU
- Not listed
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,858.01 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product with a ceiling value of $3,659.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order is scheduled...
- The Defense Logistics Agency awarded a $2,195.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The order is scheduled for completion by June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,659.15 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5 mL, a meningococcal vaccine. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with a ceiling value of $18,340.29. This firm fixed-price delivery order, which must be completed by September 16, 2025, was awarded competitively with no set-aside designation. The award was issued from Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary place...
- The Defense Logistics Agency awarded a $237,587.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 vial (meningococcal conjugate vaccine) with completion targeted for August 27, 2025. This non-set-aside award, issued on August 26, 2025, represents a single delivery order fulfillment from AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9QUDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime indefinite delivery vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen routinely fulfills vaccine and medication deliveries for military and veteran healthcare systems through DLA's comprehensive pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 8/12/25 |